Todd C. Skaar
- Genetics top 0.2%
- Pharmacology top 0.02%
- Oncology top 1%
- Molecular Biology top 5%
- Cancer Research top 1%
- Co-authors
- David A. FlockhartRobert ClarkeZeruesenay DestaJames M. RaeAnne NguyenAndrea GaedigkFabio LeonessaTeri E. Klein
- Topics
- Estrogen and related hormone effects (69 papers)Pharmacogenetics and Drug Metabolism (62 papers)Cancer Treatment and Pharmacology (17 papers)
- Cited by
- PharmacologyGeneticsOncology
- Partner nations
- United StatesCanadaChina
In The Last Decade
Todd C. Skaar
207 papers receiving 8.2k citations
Hit Papers
Peers
Comparison fields: 5 of 144
- Genetics 3.2k
- Pharmacology 3.0k
- Oncology 2.4k
- Molecular Biology 2.3k
- Cancer Research 1.2k
Countries citing papers authored by Todd C. Skaar
This map shows the geographic impact of Todd C. Skaar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Todd C. Skaar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Todd C. Skaar more than expected).
Fields of papers citing papers by Todd C. Skaar
This network shows the impact of papers produced by Todd C. Skaar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Todd C. Skaar. The network helps show where Todd C. Skaar may publish in the future.
Co-authorship network of co-authors of Todd C. Skaar
This figure shows the co-authorship network connecting the top 25 collaborators of Todd C. Skaar. A scholar is included among the top collaborators of Todd C. Skaar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Todd C. Skaar. Todd C. Skaar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 4 | |
| 3 | 23 | |
| 4 | 2 | |
| 5 | 11 | |
| 6 | 5 | |
| 7 | 13 | |
| 8 | Implementation of a Renal Precision Medicine Program: Clinician Attitudes and Acceptance | 1 |
| 9 | 41 | |
| 10 | MicroRNA 362-3p Reduces hERG-related Current and Inhibits Breast Cancer Cells Proliferation | 1 |
| 11 | 22 | |
| 12 | Rifampin modulation of xeno- and endobiotic conjugating enzyme mRNA expression and associated microRNAs in human hepatocytes | 3 |
| 13 | Clinical pharmacogenetics implementation consortium guideline (CPIC) for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants: 2016 update | 57 |
| 14 | Population Pharmacokinetic Modeling To Estimate the Contributions of Genetic and Nongenetic Factors to Efavirenz Disposition | 1 |
| 15 | 18 | |
| 16 | 39 | |
| 17 | Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Selective Serotonin Reuptake Inhibitors | 51 |
| 18 | 8 | |
| 19 | 31 | |
| 20 | Diindolylmethane inhibits indoleamine 2,3-dioxygenase activity in breast cancer cells | 1 |
About Todd C. Skaar
Todd C. Skaar is a scholar working on Pharmacology, Genetics and Cancer Research, having authored 214 papers that have together received 8.4k indexed citations. Recurring topics across this work include Estrogen and related hormone effects (69 papers), Pharmacogenetics and Drug Metabolism (62 papers) and Cancer Treatment and Pharmacology (17 papers). The work is most often cited by research in Pharmacology (3.0k citations), Genetics (3.2k citations) and Oncology (2.4k citations). Todd C. Skaar has collaborated with scholars based in United States, Canada and China. Frequent co-authors include David A. Flockhart, Robert Clarke, Zeruesenay Desta, James M. Rae, Anne Nguyen, Andrea Gaedigk, Fabio Leonessa, Teri E. Klein, Daniel F. Hayes and Vered Stearns. Their work appears in journals such as Circulation, Nature Communications and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.